Allspring Global Investments Holdings, LLC Alpine Immune Sciences, Inc. Transaction History

Allspring Global Investments Holdings, LLC

$59.4 Billion
Q2 2024

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 18, 2024	BUY	$17.75 - $41.6 $87,436 - $204,921	4,926 Added 331.05%	6,414 $254,000
Q4 2023 Jan 25, 2024	BUY	$8.54 - $20.22 $11,204 - $26,528	1,312 Added 745.45%	1,488 $28,000
Q3 2023 Oct 27, 2023	BUY	$10.13 - $13.98 $1,782 - $2,460	176 New	176 $2,000
Q4 2022 Jan 23, 2023	SELL	$5.45 - $7.35 $685,261 - $924,159	-125,736 Reduced 96.58%	4,453 $0
Q3 2022 Oct 26, 2022	SELL	$6.89 - $9.39 $45,529 - $62,049	-6,608 Reduced 4.83%	130,189 $937,000
Q2 2022 Jul 25, 2022	BUY	$6.71 - $9.52 $804,763 - $1.14 Million	119,935 Added 711.27%	136,797 $1.16 Million
Q1 2022 May 02, 2022	BUY	$6.41 - $13.89 $69,452 - $150,498	10,835 Added 179.77%	16,862 $151,000
Q4 2021 Jan 28, 2022	BUY	$10.41 - $13.95 $62,741 - $84,076	6,027 New	6,027 $83,000

Others Institutions Holding ALPN

# of Institutions

Shares Held

56.2K

Call Options Held

Put Options Held

View Full List

About ALPINE IMMUNE SCIENCES, INC.

Ticker ALPN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 44,006,700
Description
Alpine Immune Sciences, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of protein-based immunotherapies for the treatment of cancer, autoimmune/inflammatory disorders, and other diseases. Its product pipeline includes ALPN-101, an inducible T cell costimulator (ICOS)/cluster of differentiation 28 (CD28...

More about ALPN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Allspring Global Investments Holdings, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Allspring Global Investments Holdings, LLC with notifications on news.

Account